CN113133500B - A feed additive for relieving altitude sickness of dairy cows and its using method and feed - Google Patents
A feed additive for relieving altitude sickness of dairy cows and its using method and feed Download PDFInfo
- Publication number
- CN113133500B CN113133500B CN202010052732.0A CN202010052732A CN113133500B CN 113133500 B CN113133500 B CN 113133500B CN 202010052732 A CN202010052732 A CN 202010052732A CN 113133500 B CN113133500 B CN 113133500B
- Authority
- CN
- China
- Prior art keywords
- dairy cows
- feed additive
- feed
- concentration
- altitude sickness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000283690 Bos taurus Species 0.000 title claims abstract description 139
- 235000013365 dairy product Nutrition 0.000 title claims abstract description 104
- 239000003674 animal food additive Substances 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 title claims abstract description 34
- 208000008445 altitude sickness Diseases 0.000 title claims description 62
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 25
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 claims abstract description 24
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 claims abstract description 24
- 239000004475 Arginine Substances 0.000 claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims description 23
- 239000008280 blood Substances 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 240000004658 Medicago sativa Species 0.000 claims description 4
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 240000002791 Brassica napus Species 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- 241001668545 Pascopyrum Species 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 235000019764 Soybean Meal Nutrition 0.000 claims description 2
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 claims description 2
- 229910000020 calcium bicarbonate Inorganic materials 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000004460 silage Substances 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000004455 soybean meal Substances 0.000 claims description 2
- 235000015099 wheat brans Nutrition 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 206010067484 Adverse reaction Diseases 0.000 abstract description 4
- 230000006838 adverse reaction Effects 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 239000003640 drug residue Substances 0.000 abstract description 4
- 230000001739 rebound effect Effects 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 27
- 239000001301 oxygen Substances 0.000 description 27
- 230000000694 effects Effects 0.000 description 14
- 210000003743 erythrocyte Anatomy 0.000 description 13
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 12
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 11
- 229940109738 hematin Drugs 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 230000037213 diet Effects 0.000 description 7
- 239000008267 milk Substances 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- 206010039163 Right ventricular failure Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004517 glycocalyx Anatomy 0.000 description 1
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Birds (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种缓解奶牛高原病的饲料添加剂及其使用方法和饲料。The present invention relates to a feed additive for alleviating high altitude sickness in dairy cows, a method for using the same, and a feed.
背景技术Background technique
青藏高原平均海拔超过4500米,被称为“世界屋脊”,是世界上海拔最高、面积最大的高原。气候寒冷、空气干燥、空气中的氧气分压低、强紫外线是青藏高原典型的环境特点。氧平衡状态的维持是需氧生物生存的根本前提,而青藏高原是全球平均海拔最高的地理单元,此地域大气氧分压仅为海平面的53%-62%低氧成为制约青藏高原上动物生存的主要因素。The average altitude of the Qinghai-Tibet Plateau is more than 4,500 meters, known as the "roof of the world". It is the highest and largest plateau in the world. Cold climate, dry air, low partial pressure of oxygen in the air, and strong ultraviolet rays are typical environmental characteristics of the Qinghai-Tibet Plateau. The maintenance of oxygen balance is the fundamental prerequisite for the survival of aerobic organisms, and the Qinghai-Tibet Plateau is the geographical unit with the highest average altitude in the world. The atmospheric oxygen partial pressure in this region is only 53%-62% of sea level. major factor in survival.
牦牛能适应高海拔低氧环境,长期以来成为高海拔地区居民牛奶和牛肉的主要来源。近年来,随着西藏自治区经济发展和人民生活水平的提高,对于乳制品和牛肉的需求量逐年增加。西藏自治区的牦牛存栏量有395万头,但是牦牛的生产周期较长且产奶量低,因而引进产奶量高的荷斯坦牛成为解决奶源紧缺的主要途径。荷斯坦奶牛起源于荷兰的莱茵河三角洲地区,以其产奶量高、乳品质好的特点成为全世界养殖最多的奶牛,但是高海拔低氧环境对于荷斯坦奶牛是一个巨大的生理挑战,在海拔高于2000米的地区低氧引起的肺动脉高压是导致奶牛死亡的主要原因,其中在高原低氧环境下特发的肺水肿,由低氧引起肺动脉高压和右心衰竭导致奶牛死亡的疾病,被称为荷斯坦奶牛和娟姗牛高原病(Brisketdisease, BD)。青藏高原养殖的荷斯坦奶牛、娟姗牛、安格斯肉牛等品种均有发生高原病的报道,尤以西藏地区发病率最高。西藏自治区曾多次从内地引进荷斯坦奶牛,但是均以高原病引起的奶牛死亡比例太高而失败。因此,高原病成为阻碍西藏地区乃至高海拔地区奶牛养殖产业发展的主要原因,已经成为制约高原地区奶牛健康快速发展的关键技术瓶颈。Yak can adapt to high altitude and low oxygen environment, and has long been the main source of milk and beef for residents in high altitude areas. In recent years, with the economic development of the Tibet Autonomous Region and the improvement of people's living standards, the demand for dairy products and beef has increased year by year. There are 3.95 million yaks in the Tibet Autonomous Region, but the production cycle of yaks is long and the milk yield is low. Therefore, the introduction of Holstein cattle with high milk yield has become the main way to solve the shortage of milk sources. Holstein dairy cows originated from the Rhine delta region of the Netherlands. They have become the most farmed dairy cows in the world due to their high milk yield and good milk quality. However, the high altitude and low oxygen environment is a huge physiological challenge for Holstein dairy cows. Pulmonary arterial hypertension caused by hypoxia at altitudes above 2000 meters is the main cause of death of dairy cows, among which pulmonary edema idiopathic in high altitude hypoxic environment, pulmonary arterial hypertension and right heart failure caused by hypoxia lead to the death of dairy cows, Known as Holstein and Jersey cattle altitude sickness (Brisket disease, BD). Altitude sickness has been reported in Holstein dairy cows, Jersey cows, Angus beef cattle and other breeds raised on the Qinghai-Tibet Plateau, with the highest incidence in Tibet. The Tibet Autonomous Region has introduced Holstein dairy cows from the mainland many times, but all of them failed because the mortality rate of dairy cows caused by altitude sickness was too high. Therefore, altitude sickness has become the main reason hindering the development of dairy cattle breeding industry in Tibet and even high-altitude areas, and has become a key technical bottleneck restricting the healthy and rapid development of dairy cattle in plateau areas.
针对高原病给机体带来的诸如代谢变化等一系列症状,目前国内外所采取的防控措施主要包括高压氧、化学药物(乙酰唑胺、地塞米松、盐酸苄达明等)、中草药(红景天、丹参、复方党参等)等,尽管在一定程度上上述措施能起到缓解高原病的效果,但各个措施均存在明显的缺陷。(1)将发生高原病的奶牛关进高压氧仓进行治疗,此方法具有明显的缺陷型:高压氧仓运行成本高,普通牧民无法承受运行成本;由于高压氧仓容积有限,由此造成对奶牛高压氧治疗数量也受到极大限制,对于一个上千头奶牛的规模牛场来说,高原病奶牛占到三分之一左右,若建设一个如此大规模的高压氧仓,会使建设成本显著增加,从而使牛场背负极大的经济压力,增加生产成本,降低牛场经济效益;高压氧治疗治标不治本,易复发。(2)化学药物治疗,容易造成药物残留,对奶制品的食品安全构成威胁,此外,还会对奶牛造成不良反应,对机体造成副作用。(3)中草药主要缺陷在于效果不明显,同时停药后,会出现反弹效应;而且,由于这些中草药均为混合物,其有效成分不明确,以至于其对机体作用机制亦不清楚。因此,针对现有技术中存在的缺陷和不足,获得一种成本低廉、使用方便、缓解效果好的缓解奶牛高原病的饲料添加剂,对于有效缓解奶牛高原病以及促进高海拔地区奶牛养殖产业发展具有十分重要的意义。Aiming at a series of symptoms such as metabolic changes caused by altitude sickness, the prevention and control measures taken at home and abroad mainly include hyperbaric oxygen, chemical drugs (acetazolamide, dexamethasone, benzedamine hydrochloride, etc.), Chinese herbal medicine ( Rhodiola rosea, Salvia miltiorrhiza, compound Codonopsis, etc.), although the above measures can alleviate altitude sickness to a certain extent, but each measure has obvious defects. (1) The cows with altitude sickness are put into the hyperbaric oxygen chamber for treatment. This method has obvious defects: the operation cost of the hyperbaric oxygen chamber is high, and the ordinary herdsmen cannot afford the operation cost; due to the limited volume of the hyperbaric oxygen chamber, the The number of cows treated with hyperbaric oxygen is also greatly limited. For a large-scale dairy farm with thousands of cows, cows with altitude sickness account for about one-third. If such a large-scale hyperbaric oxygen chamber is constructed, the construction cost will be increased. Significantly increased, so that the negative economic pressure on cattle farms will increase, increase production costs, and reduce the economic benefits of cattle farms; hyperbaric oxygen therapy can cure the symptoms but not the root cause, and it is easy to recur. (2) Chemical drug treatment is likely to cause drug residues, posing a threat to the food safety of dairy products. In addition, it will also cause adverse reactions to dairy cows and side effects to the body. (3) The main defect of Chinese herbal medicine is that the effect is not obvious, and there will be a rebound effect after stopping the drug at the same time; moreover, since these Chinese herbal medicines are all mixtures, their active ingredients are not clear, so that their mechanism of action on the body is also unclear. Therefore, in view of the defects and deficiencies in the prior art, to obtain a low cost, easy to use, and good alleviation effect of a feed additive for relieving high altitude sickness in dairy cows, it is useful for effectively relieving high altitude sickness in dairy cows and promoting the development of dairy cattle breeding industry in high-altitude areas. very important meaning.
发明内容SUMMARY OF THE INVENTION
本发明要解决的技术问题是克服现有技术的不足,获得一种成本低廉、使用方便、处理效果好的缓解奶牛高原病的饲料添加剂及其使用方法和饲料。The technical problem to be solved by the present invention is to overcome the deficiencies of the prior art and obtain a feed additive with low cost, convenient use and good treatment effect for relieving high altitude sickness in dairy cows, its use method and feed.
为解决上述技术问题,本发明采用以下技术方案:In order to solve the above-mentioned technical problems, the present invention adopts the following technical solutions:
一种缓解奶牛高原病的饲料添加剂,所述饲料添加剂包括红景天苷、牲血素和精酸素;所述红景天苷、牲血素和精酸素的质量比为1∶3000~4000∶ 3000~4000。A feed additive for relieving high altitude sickness in dairy cows, the feed additive comprises salidroside, hematin and arginine; the mass ratio of the salidroside, hematin and arginine is 1:3000-4000: 3000~4000.
上述的缓解奶牛高原病的饲料添加剂,进一步改进的,所述红景天苷、牲血素和精酸素的质量比为1∶3333∶3333。The above-mentioned feed additive for relieving high altitude sickness in dairy cows is further improved, and the mass ratio of salidroside, hemoglobin and arginine is 1:3333:3333.
作为一个总的技术构思,本发明还提供了一种上述的缓解奶牛高原病的饲料添加剂的使用方法,包括以下步骤:将缓解奶牛高原病的饲料添加剂与日粮混合,所得饲料用于喂养奶牛。As a general technical concept, the present invention also provides a method of using the above-mentioned feed additive for alleviating high altitude sickness in dairy cows, comprising the following steps: mixing the feed additive for alleviating high altitude sickness in dairy cows with a ration, and the obtained feed is used for feeding dairy cows .
上述的使用方法,进一步改进的,所述缓解奶牛高原病的饲料添加剂的喂养量为35 g·头-1·天-1~45 g·头-1·天-1。The above method of use is further improved, and the feeding amount of the feed additive for relieving altitude sickness in dairy cows is 35 g·head -1 ·day -1 to 45 g·head -1 ·day -1 .
上述的使用方法,进一步改进的,所述缓解奶牛高原病的饲料添加剂的喂养量为40g·头-1·天-1。The above-mentioned method of use is further improved, and the feeding amount of the feed additive for relieving altitude sickness in dairy cows is 40 g·head −1 ·day −1 .
上述的使用方法,进一步改进的,所述奶牛为荷斯坦奶牛或娟姗牛。The above-mentioned method of use is further improved, and the cow is a Holstein cow or a Jersey cow.
上述的使用方法,进一步改进的,所述日粮中按照质量百分比计包括以下组分:The above-mentioned method of use is further improved, and the ration includes the following components according to mass percentage:
苜蓿颗粒 5.56%,Alfalfa Granules 5.56%,
青贮玉米 5.56%,Silage corn 5.56%,
小麦草 33.33%,Wheatgrass 33.33%,
苜蓿草 38.89%,Alfalfa 38.89%,
精料 16.66;Concentrate 16.66;
所述精料中按照质量百分比计包括以下组分:The concentrate includes the following components according to mass percentage:
玉米 45.5%,Corn 45.5%,
燕麦 3.5%,Oatmeal 3.5%,
麦麸 5%,5% wheat bran,
豆粕 15.5%,Soybean meal 15.5%,
菜籽饼 20%,Rapeseed cake 20%,
碳酸氢钙 0.5%,Calcium bicarbonate 0.5%,
脂肪粉 6%,
食盐 1.5%,Table salt 1.5%,
预混料 2.5%;Premix 2.5%;
所述预混料中含有以下组分:浓度为113.85g/kg的MgSO4•H2O、浓度为2.69 g/kg的FeSO4•7H2O、浓度为2.55 g/kg的 CuSO4•5H2O、浓度为9.54 g/kg的 MnSO4•H2O、浓度为9.60 g/kg 的ZnSO4•H2O、浓度为0.030 g/kg 的Na2SeO3、浓度为0.060 g/kg 的KI、浓度为0.180 g/kg的 CoCl2•6H2O、浓度为500000 IU/kg的维生素A、浓度为60 kIU/kg的维生素D、浓度为2000 IU/kg的维生素E。The premix contains the following components: MgSO 4 •H 2 O at a concentration of 113.85 g/kg, FeSO 4 • 7H 2 O at a concentration of 2.69 g/kg, CuSO 4 • 5H at a concentration of 2.55 g/kg 2 O, MnSO 4 •H 2 O at a concentration of 9.54 g/kg, ZnSO 4 •H 2 O at a concentration of 9.60 g/kg, Na 2 SeO 3 at a concentration of 0.030 g/kg,
上述的使用方法,进一步改进的,所述奶牛的喂养过程中,每天早晚各喂养一次,共喂养50天;所述奶牛的喂养过程中控制日剩料量为投料量的5%~10%。The above-mentioned method of use is further improved. During the feeding process of the dairy cows, the cows are fed once in the morning and evening for a total of 50 days; the daily residual feed amount is controlled to be 5% to 10% of the feeding amount during the feeding process of the dairy cows.
上述的使用方法,进一步改进的,所述奶牛的喂养过程中,在喂养饲料之前还包括用日粮喂养奶牛10天。The above-mentioned method of use is further improved. In the feeding process of the dairy cow, before feeding the feed, the dairy cow is fed with the ration for 10 days.
作为一个总的技术构思,本发明还提供了一种缓解奶牛高原病的饲料,所述饲料包括缓解奶牛高原病的饲料添加剂,所述饲料添加剂包括红景天苷、牲血素和精酸素;所述红景天苷、牲血素和精酸素的质量比为1∶3000~4000∶ 3000~4000;所述饲料中饲料添加剂的质量百分含量为0.15%~0.25%。进一步改进的,所述饲料添加剂包括红景天苷、牲血素和精酸素;所述红景天苷、牲血素和精酸素的质量比为1∶3333∶3333。As a general technical concept, the present invention also provides a feed for relieving high altitude sickness in dairy cows, the feed comprising a feed additive for relieving high altitude sickness in dairy cows, and the feed additive comprises salidroside, hemoglobin and arginine; The mass ratio of the salidroside, hemoglobin and arginine is 1:3000-4000:3000-4000; the mass percentage content of the feed additive in the feed is 0.15%-0.25%. In a further improvement, the feed additive includes salidroside, hematin and arginine; the mass ratio of the salidroside, hematin and arginine is 1:3333:3333.
与现有技术相比,本发明的优点在于:Compared with the prior art, the advantages of the present invention are:
(1)本发明提供了一种缓解奶牛高原病的饲料添加剂,包括红景天苷、牲血素和精酸素,其中红景天苷、牲血素和精酸素的质量比为1∶3000~4000∶3000~4000。本发明中,红景天苷来源于中草药红景天,红景天苷能够通过干扰细胞代谢、改变细胞外衣的性质抑制肿瘤细胞增殖同时还能够提高T淋巴细胞转化率和吞噬细胞活力,增强免疫力,可缓和压力所致心血管组织损伤和功能紊乱,防止在急冻状态下因周围环境压力继发的心脏收缩力下降和有助于稳定收缩性,同时能够增强红细胞运输氧的能力;牲血素可促使红细胞自骨髓向血液中释放,进而转化为成熟红细胞,而且有稳定红细胞膜,提高红细胞膜抗氧化酶的功能;精酸素是精氨酸合成的前体物质,精氨酸在机体代谢过程中能产生NO,而NO在缓解高原反过程中具有重要作用,因而本发明中通过将红景天苷、牲血素和精酸素按照一定的比例混合制成的缓解高原病的饲料添加剂,从机体生理生化层面着手,提高高原奶牛血液中红细胞运输氧的能力,调控奶牛胃肠道微生物区系的平衡,以达到缓解高原病的目的。(1) The present invention provides a feed additive for relieving high altitude sickness in dairy cows, including salidroside, hematin and arginine, wherein the mass ratio of salidroside, hematin and arginine is 1:3000~ 4000: 3000~4000. In the present invention, salidroside is derived from Chinese herbal medicine Rhodiola, and salidroside can inhibit tumor cell proliferation by interfering with cell metabolism and changing the properties of cell coats, and can also improve T lymphocyte transformation rate and phagocytic cell activity, and enhance immunity. It can alleviate the damage and dysfunction of cardiovascular tissue caused by pressure, prevent the decrease of cardiac contractility caused by ambient pressure in the freezing state, and help stabilize contractility, and at the same time, it can enhance the ability of red blood cells to transport oxygen; Hemoglobin can promote the release of red blood cells from the bone marrow into the blood, and then convert them into mature red blood cells, and can stabilize the red blood cell membrane and improve the function of red blood cell membrane antioxidant enzymes; arginine is the precursor of arginine synthesis, and arginine in the body. NO can be produced in the process of metabolism, and NO plays an important role in the process of alleviating altitude sickness. Therefore, in the present invention, the feed additive for alleviating altitude sickness is prepared by mixing salidroside, hemoglobin and arginin in a certain proportion. , from the physiological and biochemical aspects of the body, improve the ability of red blood cells to transport oxygen in the blood of high altitude dairy cows, and regulate the balance of the gastrointestinal microflora of dairy cows, so as to achieve the purpose of alleviating altitude sickness.
(2)本发明缓解奶牛高原病的饲料添加剂中,各成分为植物提取物及天然活性成分,避免的化学药物残留,防止对奶制品造成食品安全威胁。(2) In the feed additive for relieving altitude sickness of dairy cows of the present invention, each component is plant extract and natural active component, which avoids chemical drug residues and prevents food safety threats to dairy products.
(3)本发明缓解奶牛高原病的饲料添加剂,从奶牛生理生化层面进行实施,有利于解析本添加剂的作用机制。(3) The feed additive for relieving high altitude sickness in dairy cows of the present invention is implemented from the physiological and biochemical aspects of dairy cows, which is beneficial to analyze the action mechanism of the additive.
(4)本发明缓解奶牛高原病的饲料添加剂,饲喂时直接添加到奶牛饲料中即可,应用简单,适合高原牧民以及规模化养殖场,与高压氧仓相比,极大的降低了生产成本。(4) The feed additive for relieving the altitude sickness of dairy cows of the present invention can be directly added to the feed of dairy cows during feeding. The application is simple and suitable for plateau herdsmen and large-scale farms. Compared with the hyperbaric oxygen chamber, the production is greatly reduced. cost.
由此可见,本发明缓解奶牛高原病的饲料添加剂,不仅能够降低高原奶牛高原病发病率和死亡率,而且还能够降低治疗成本,同时还能够避免化学药物残留,保证乳制品食品安全,更为重要的是,还能降低或彻底去除奶牛机体的不良反应和反弹效应,具有成本低廉、使用方便、缓解效果好等优点,能够广泛用于缓解奶牛的高原病,对于促进高海拔地区奶牛养殖产业发展具有十分重要的意义。It can be seen that the feed additive for relieving high altitude sickness in dairy cows of the present invention can not only reduce the morbidity and mortality of high altitude sickness in high altitude dairy cows, but also reduce the cost of treatment, and at the same time, it can avoid chemical drug residues, ensure the food safety of dairy products, and improve food safety. Importantly, it can also reduce or completely remove the adverse reactions and rebound effects of dairy cows. It has the advantages of low cost, convenient use, and good relief effect. It can be widely used to relieve altitude sickness in dairy cows. Development is very important.
(5)本发明还提供了一种缓解奶牛高原病的饲料添加剂的使用方法,通过将饲料添加剂与日粮混合即可直接用于喂养奶牛,具有操作简单、使用方便等优点,并兼具良好的推广性,可实现饲料添加剂在缓解奶牛高原病中的广泛应用。(5) The present invention also provides a method for using a feed additive for relieving altitude sickness in dairy cows, which can be directly used for feeding dairy cows by mixing the feed additive with the ration, which has the advantages of simple operation, convenient use, etc. The popularization of feed additives can realize the wide application of feed additives in alleviating high altitude sickness in dairy cows.
(6)本发明还提供了一种缓解奶牛高原病的饲料,包括日粮和缓解奶牛高原病的饲料添加剂,其中饲料添加剂的加入,不仅能够降低高原奶牛高原病发病率和死亡率,而且还能够降低治疗成本,同时还能够避免化学药物残留,保证乳制品食品安全,更为重要的是,还能降低或彻底去除奶牛机体的不良反应和反弹效应,适用于缓解奶牛高原病,有着很高的使用价值和很好的应用前景。(6) The present invention also provides a feed for alleviating high altitude sickness in dairy cows, including a ration and a feed additive for alleviating high altitude sickness in dairy cows, wherein the addition of feed additives can not only reduce the incidence and mortality of high altitude dairy cows, but also It can reduce the cost of treatment, avoid chemical residues, ensure the safety of dairy products, and more importantly, reduce or completely remove the adverse reactions and rebound effects of dairy cows. It is suitable for alleviating high altitude sickness in dairy cows. The use value and good application prospect.
附图说明Description of drawings
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整的描述。To make the purposes, technical solutions, and advantages of the embodiments of the present invention clearer, the following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention.
图1为本发明实施例2中不同处理方式对荷斯坦奶牛死亡率的影响图。FIG. 1 is a graph showing the effect of different treatment methods on the mortality of Holstein dairy cows in Example 2 of the present invention.
图2为本发明实施例2中不同处理方式对娟珊牛死亡率的影响图。2 is a graph showing the effect of different treatment methods on the mortality of Jersey cattle in Example 2 of the present invention.
图3为本发明实施例2中试验组和高反组荷斯坦奶牛的红细胞形貌图,其中(a)为高反组,(b)为试验组。Fig. 3 is a topography of red blood cells of Holstein cows in the test group and the high-resistance group in Example 2 of the present invention, wherein (a) is the high-resistance group, and (b) is the test group.
具体实施方式Detailed ways
以下结合说明书附图和具体优选的实施例对本发明作进一步描述,但并不因此而限制本发明的保护范围。The present invention will be further described below with reference to the accompanying drawings and specific preferred embodiments, but the protection scope of the present invention is not limited thereby.
实施例1Example 1
一种缓解奶牛高原病的饲料添加剂,由红景天苷、牲血素和精酸素组成,其中红景天苷、生血素和精酸素的质量比为1∶3333∶3333。A feed additive for relieving high altitude sickness of dairy cows is composed of salidroside, hemoglobin and arginin, wherein the mass ratio of salidroside, hematin and arginin is 1:3333:3333.
一种缓解奶牛高原病的饲料添加剂的制备方法,包括以下步骤:以红景天苷、牲血素以及精酸素为原料,以质量比为1∶3333∶3333的比例,按照三级混合法混合均匀,得到缓解奶牛高原病的饲料添加剂。A method for preparing a feed additive for relieving high altitude sickness in dairy cows, comprising the following steps: using salidroside, hemoglobin and arginine as raw materials, and mixing them in a mass ratio of 1:3333:3333 according to a three-level mixing method Evenly, the feed additive for relieving the altitude sickness of dairy cows is obtained.
一种缓解奶牛高原病的饲料,包括实施例1中的缓解奶牛高原病的饲料添加剂和日粮,其中该饲料中饲料添加剂的质量百分含量为0.22%。日粮中各组分及它们的质量含量如表1所示。A feed for alleviating high altitude sickness in dairy cows, comprising the feed additive for alleviating high altitude sickness in dairy cows and a ration in Example 1, wherein the mass percentage of the feed additive in the feed is 0.22%. The components in the diet and their mass content are shown in Table 1.
本实施例中,预混料包括以下组分:浓度为113.85g/kg的MgSO4•H2O、浓度为2.69g/kg 的FeSO4•7H2O、浓度为2.55 g/kg的 CuSO4•5H2O、浓度为9.54 g/kg的 MnSO4•H2O、浓度为9.60 g/kg 的ZnSO4•H2O、浓度为0.030 g/kg 的Na2SeO3、浓度为0.060 g/kg 的KI、浓度为0.180 g/kg的 CoCl2•6H2O、浓度为500000 IU/kg的维生素A、浓度为60 kIU/kg的维生素D、浓度为2000 IU/kg的维生素E。In this example, the premix includes the following components: MgSO 4 ·H 2 O with a concentration of 113.85 g/kg, FeSO 4 ·7H 2 O with a concentration of 2.69 g/kg, and CuSO 4 with a concentration of 2.55 g/kg • 5H 2 O, MnSO 4 at a concentration of 9.54 g/kg • H 2 O, ZnSO 4 at a concentration of 9.60 g/kg • H 2 O, Na 2 SeO 3 at a concentration of 0.030 g/kg, at a concentration of 0.060 g/kg kg of KI, CoCl 2 •6H 2 O at a concentration of 0.180 g/kg, vitamin A at a concentration of 500,000 IU/kg, vitamin D at a concentration of 60 kIU/kg, and vitamin E at a concentration of 2000 IU/kg.
对比例1Comparative Example 1
一种饲料添加剂,由红景天苷和牲血素组成,其中红景天苷和牲血素的质量比为1∶3333。A feed additive is composed of salidroside and salicylic acid, wherein the mass ratio of salidroside and salicylic acid is 1:3333.
对比例2Comparative Example 2
一种饲料添加剂,由红景天苷和精酸素组成,其中红景天苷和精酸素的质量比为1∶3333。A feed additive is composed of salidroside and arginine, wherein the mass ratio of salidroside and arginine is 1:3333.
对比例3Comparative Example 3
一种饲料添加剂,由牲血素和精酸素组成,其中牲血素和精酸素的质量比为1∶1。A feed additive is composed of hematin and arginine, wherein the mass ratio of hematin and arginine is 1:1.
对比例4Comparative Example 4
一种饲料添加剂,由红景天苷、牲血素和精酸素组成,其中红景天苷、生血素和精酸素的质量比为1∶5000∶5000。A feed additive is composed of salidroside, hematin and arginine, wherein the mass ratio of salidroside, hematin and arginine is 1:5000:5000.
实施例2Example 2
一种缓解奶牛高原病的饲料添加剂的使用方法,以高标准良种奶牛养殖中心饲养的200头成年荷斯坦奶牛和200头成年娟珊牛为试验对象,包括以下步骤:按照缓解奶牛高原病的饲料添加剂的喂养量为40 g·头-1·天-1,将实施例1中的缓解奶牛高原病的饲料添加剂与日粮(日粮的组成如表1所示)混合,所得饲料用于喂养奶牛,具体为:每天06:30和18:30各饲喂一次,保证日剩料量为投料量的5%-10%,记录采食量,自由饮水。共喂养60天,其中前10天为预饲期,仅用日粮喂养;后50天正试期,用饲料添加剂和日粮混合后得到的饲料进行喂养。A method for using a feed additive for relieving altitude sickness in dairy cows, taking 200 adult Holstein dairy cows and 200 adult Jersey cows raised in a high-standard dairy cattle breeding center as test objects, comprising the following steps: The feeding amount of the additive is 40 g·head -1 ·day -1 . The feed additive for relieving high altitude sickness in dairy cows in Example 1 is mixed with the ration (the composition of the ration is shown in Table 1), and the obtained feed is used for feeding Dairy cows, specifically: feed once a day at 06:30 and 18:30, ensure that the daily residual feed amount is 5%-10% of the feeding amount, record the feed intake, and drink water freely. They were fed for a total of 60 days, of which the first 10 days were the pre-feeding period, and they were fed only with the diet; the latter 50 days of the positive trial period were fed with the feed obtained by mixing the feed additives and the diet.
对照组一:将日粮喂养奶牛,其他条件与试验组相同。Control group 1: The diet was fed to dairy cows, and other conditions were the same as the experimental group.
对照组二:将对比例1中的饲料添加剂代替本发明实施例1中的饲料添加剂,与日粮混合后用于喂养奶牛,其他条件与试验组相同。Control group 2: the feed additive in Comparative Example 1 was replaced by the feed additive in Example 1 of the present invention, mixed with the ration and used to feed dairy cows, and other conditions were the same as in the experimental group.
对照组三:将对比例2中的饲料添加剂代替本发明实施例1中的饲料添加剂,与日粮混合后用于喂养奶牛,其他条件与试验组相同。Control group 3: The feed additive in Comparative Example 2 replaced the feed additive in Example 1 of the present invention, mixed with the ration and used to feed dairy cows, and other conditions were the same as in the experimental group.
对照组四:将对比例3中的饲料添加剂代替本发明实施例1中的饲料添加剂,与日粮混合后用于喂养奶牛,其他条件与试验组相同。Control group 4: The feed additive in Comparative Example 3 replaced the feed additive in Example 1 of the present invention, mixed with the ration and used to feed dairy cows, and other conditions were the same as in the experimental group.
对照组五:将对比例4中的饲料添加剂代替本发明实施例1中的饲料添加剂,与日粮混合后用于喂养奶牛,其他条件与试验组相同。Control group 5: The feed additive in Comparative Example 4 replaced the feed additive in Example 1 of the present invention, mixed with the ration and used to feed dairy cows, and other conditions were the same as in the experimental group.
喂养期间,记录奶牛死亡数量,计算奶牛死亡率,结果如图1、2所示。由图1和图2可知,对照组一中没有添加饲料添加剂,对应的荷斯坦奶牛的死亡率为15%,娟珊牛的死亡率为10%,而日粮中添加了本发明实施例1中的饲料添加剂后,对应的荷斯坦奶牛的死亡率为4%,娟珊牛的死亡率为2%。由此可见,试验组(添加了本发明的饲料添加剂)中奶牛死亡率远低于对照组中奶牛的死亡率。综上,日粮中添加本发明所涉及的缓解高原反应的饲料添加剂,能有效减低荷斯坦奶牛以及娟珊牛的死亡率,具有极显著的效果。During the feeding period, the number of deaths of dairy cows was recorded and the mortality of dairy cows was calculated. The results are shown in Figures 1 and 2. As can be seen from Fig. 1 and Fig. 2, no feed additive was added in the control group 1, the mortality rate of the corresponding Holstein cows was 15%, and the mortality rate of Jersey cattle was 10%, and Example 1 of the present invention was added in the diet. The corresponding mortality rate of Holstein cows was 4% and that of Jersey cows was 2%. It can be seen that the mortality rate of dairy cows in the test group (added with the feed additive of the present invention) is much lower than that in the control group. To sum up, adding the feed additive for alleviating altitude sickness involved in the present invention to the diet can effectively reduce the mortality of Holstein dairy cows and Jersey cattle, and has a very significant effect.
喂养的最后一天,利用便捷式血氧饱和度测量仪通过奶牛耳朵检测两组奶牛血氧饱和度、心率,通过尾根静脉采血,检测血液运氧能力。结果如表3、4所示。On the last day of feeding, a portable blood oxygen saturation meter was used to detect blood oxygen saturation and heart rate of the two groups of cows through the cow ears, and blood was collected through the tail root vein to detect the oxygen transport capacity of the blood. The results are shown in Tables 3 and 4.
表3 不同处理方式对荷斯坦奶牛血氧饱和度及心率的影响Table 3 Effects of different treatments on blood oxygen saturation and heart rate in Holstein cows
表4 不同处理方式对娟姗牛血氧饱和度及心率的影响Table 4 Effects of different treatments on blood oxygen saturation and heart rate of Jersey cattle
由表3可知,对于荷斯坦奶牛,试验组奶牛的血氧饱和度显著的高于对照组,与此同时,心率显著低于对照组;同样,在对娟珊牛的试验中,也得到相同结果(表4)。由此表明,奶牛日粮中添加本发明涉及的饲料添加剂,能显著提高奶牛的血氧饱和度,同时降低奶牛的心率。综上,可知,本发明所涉及的饲料添加剂能够增加奶牛血液中的溶氧量,同时对奶牛的心脏具有保护作用。It can be seen from Table 3 that for the Holstein cows, the blood oxygen saturation of the cows in the experimental group was significantly higher than that of the control group, and at the same time, the heart rate was significantly lower than that of the control group; similarly, in the test of the Jersey cows, the same results were obtained. results (Table 4). Therefore, it is shown that adding the feed additive according to the present invention to the dairy cow's diet can significantly improve the blood oxygen saturation of the dairy cow and reduce the heart rate of the dairy cow at the same time. To sum up, it can be seen that the feed additive involved in the present invention can increase the dissolved oxygen in the blood of dairy cows, and at the same time has a protective effect on the heart of dairy cows.
表5 荷斯坦奶牛血液常规分析比较Table 5 Comparison of blood routine analysis of Holstein cows
表5中,高反组为:已经出现高原病反应的奶牛;高原病+添加剂组为:采用本发明的饲料添加剂喂养出现高原病反应的奶牛,其他条件与试验组相同。In Table 5, the high-response group is: the cows with altitude sickness reaction; the altitude sickness + additive group is: the dairy cows with altitude sickness reaction are fed with the feed additive of the present invention, and other conditions are the same as the test group.
由表5可知,本发明饲料添加剂均有效提高了荷斯坦奶牛血液中与抗高原病相关指标浓度,表明本发明饲料添加剂能有效提高荷斯坦奶牛的血液运输氧的能力,对预防和治疗荷斯坦奶牛高原病具有显著作用。As can be seen from Table 5, the feed additive of the present invention has effectively improved the concentration of indicators related to anti-altitude sickness in the blood of Holstein dairy cows, indicating that the feed additive of the present invention can effectively improve the blood oxygen transport ability of Holstein dairy cows, which is beneficial to the prevention and treatment of Holstein. High altitude sickness in dairy cows has a significant effect.
表6 娟珊牛血液常规分析比较Table 6 Comparison of blood routine analysis of Jersey cattle
表6中,高反组为:已经出现高原病反应的奶牛;高原病+添加剂组为:采用本发明的饲料添加剂喂养出现高原病反应的奶牛,其他条件与试验组相同。In Table 6, the high-response group is: the cows with altitude sickness reaction; the altitude sickness + additive group is: the dairy cows with altitude sickness reaction are fed with the feed additive of the present invention, and other conditions are the same as the test group.
由表6可知,本发明饲料添加剂(添加剂组)有效提高了娟珊牛血液运输氧的能力,同时表明本发明饲料添加剂对预防和治疗高原病具有显著作用。It can be seen from Table 6 that the feed additive (additive group) of the present invention effectively improves the blood oxygen transport ability of Jersey cattle, and at the same time shows that the feed additive of the present invention has a significant effect on preventing and treating altitude sickness.
图3为本发明实施例2中试验组和高反组荷斯坦奶牛的红细胞形貌图,其中(a)为高反组,(b)为试验组。由图3可知,患有高原病(高反组)的荷斯坦奶牛血液中红细胞成畸形形状—锯齿形,而饲喂本发明实施例1的饲料添加剂(试验组)的荷斯坦奶牛血液中红细胞呈正常形态—圆饼形状。由此可知,本发明饲料添加剂对维持正常的血红细胞形态具有重要作用,而血液中红细胞是血液氧气的运输工具,正常的血红细胞是保证正常供氧的基础,由此说明,本发明饲料添加剂能有效的维持奶牛血液运输氧的能力,对预防和治疗奶牛高原病具有显著作用。Fig. 3 is a topography of red blood cells of Holstein cows in the test group and the high-resistance group in Example 2 of the present invention, wherein (a) is the high-resistance group, and (b) is the test group. As can be seen from Figure 3, the red blood cells in the blood of the Holstein dairy cows suffering from altitude sickness (high-risk group) are deformed in a zigzag shape, while the red blood cells in the blood of the Holstein dairy cows fed the feed additive (test group) of Example 1 of the present invention In normal shape - round cake shape. It can be seen that the feed additive of the present invention plays an important role in maintaining the normal shape of red blood cells, and red blood cells in the blood are the transportation means of blood oxygen, and normal red blood cells are the basis for ensuring normal oxygen supply. It can effectively maintain the ability of the blood of dairy cows to transport oxygen, and has a significant effect on the prevention and treatment of high altitude sickness in dairy cows.
以上实施例仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例。凡属于本发明思路下的技术方案均属于本发明的保护范围。应该指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下的改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above embodiments are only preferred embodiments of the present invention, and the protection scope of the present invention is not limited to the above embodiments. All the technical solutions under the idea of the present invention belong to the protection scope of the present invention. It should be pointed out that for those skilled in the art, improvements and modifications without departing from the principles of the present invention should also be regarded as the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010052732.0A CN113133500B (en) | 2020-01-17 | 2020-01-17 | A feed additive for relieving altitude sickness of dairy cows and its using method and feed |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010052732.0A CN113133500B (en) | 2020-01-17 | 2020-01-17 | A feed additive for relieving altitude sickness of dairy cows and its using method and feed |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113133500A CN113133500A (en) | 2021-07-20 |
CN113133500B true CN113133500B (en) | 2022-06-07 |
Family
ID=76808331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010052732.0A Active CN113133500B (en) | 2020-01-17 | 2020-01-17 | A feed additive for relieving altitude sickness of dairy cows and its using method and feed |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113133500B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115176754A (en) * | 2022-06-10 | 2022-10-14 | 西藏三鸣饲料有限责任公司 | Feeding method for dairy cows in high-altitude areas in lactation stage |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996008169A2 (en) * | 1994-09-12 | 1996-03-21 | Ajinomoto Co., Inc. | Method for breeding cows by feeding highly condensed nutritious feed |
CN108902483A (en) * | 2018-05-25 | 2018-11-30 | 中国农业大学 | Application of the ox feed and N- carbamylglutamic acid of the carbamylglutamic acid containing N- in terms of preventing and treating pulmonary heart and lung diseases |
CN109294980A (en) * | 2018-10-15 | 2019-02-01 | 雷桅 | Root of kirilow rhodiola and rhodioside are divided into the application in cardiac-like muscle cell in stem cell directional |
-
2020
- 2020-01-17 CN CN202010052732.0A patent/CN113133500B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996008169A2 (en) * | 1994-09-12 | 1996-03-21 | Ajinomoto Co., Inc. | Method for breeding cows by feeding highly condensed nutritious feed |
CN108902483A (en) * | 2018-05-25 | 2018-11-30 | 中国农业大学 | Application of the ox feed and N- carbamylglutamic acid of the carbamylglutamic acid containing N- in terms of preventing and treating pulmonary heart and lung diseases |
CN109294980A (en) * | 2018-10-15 | 2019-02-01 | 雷桅 | Root of kirilow rhodiola and rhodioside are divided into the application in cardiac-like muscle cell in stem cell directional |
Non-Patent Citations (4)
Title |
---|
Shih-Wei, Hsu 等.Rhodiola crenulata extract counteracts the effect of hypobaric hypoxia in rat heart via redirection of the nitric oxide and arginase 1 pathway.《BMC Complementary and Alternative Medicine》.2017,第17卷第1-10页. * |
何智慧,王春平,张海燕.一氧化氮与奶牛健康养殖.《饲料研究》.2017,(第3期),第10-14页. * |
史佩,杨立霞,王楠.红景天苷在高海拔下对心血管系统的影响.《中华中医药杂志》.2017,第32卷(第11期),第5036-5038页. * |
张勇,颜天华,袁林,王秋娟.红景天苷对小牛胸主动脉内皮细胞的保护作用.《药学与临床研究》.2009,第17卷(第3期),第195-199页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113133500A (en) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3014897C (en) | Nutritional support for animals via administration of an algal derived supplement | |
CN103284017B (en) | Application of yucca in compound feed for megalobrama amblycephala and formula of feed | |
CN104397457B (en) | Improve fish gill barrier function alimentation composition, using and feed | |
CN103518965A (en) | Premix feed capable of reducing methane emission of cattle and sheep | |
CN108606269B (en) | Sports nutritional supplement and preparation method thereof | |
CN104304177A (en) | Vitamin A-rich and potassium-rich egg production method | |
CN113133500B (en) | A feed additive for relieving altitude sickness of dairy cows and its using method and feed | |
CN105661554A (en) | Silkworm chrysalis small molecule peptide chelate for improving immunity and preparation method thereof | |
CN108030808A (en) | A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component | |
CN105878397A (en) | Composition capable of regulating transportation stress of cattle and sheep | |
CN105639079A (en) | Feed capable of improving immunity of meat-type ducks | |
CN104222624A (en) | Vitamin premix for milk cow and preparation method of vitamin premix | |
CN105028978A (en) | Feed additive capable of improving intestinal function of grass carps and application of feed additive | |
CN100448475C (en) | Application of rice wine dry matter in preparation of anti-osteoporosis substances | |
CN108371709A (en) | Lycium ruthenicum tumor recovering gene enzyme | |
US20050281839A1 (en) | Spirulina composition and antiallergic food | |
CN114668079A (en) | Propagating and healthy core material, biological feed and preparation method thereof | |
CN108142936A (en) | A kind of marine organism type special medicine purposes formula food for tumor patient | |
WO2016206363A1 (en) | Use of jilin ginseng oligopeptide in preparation of anti-oxidant food product or health care food product | |
CN110585321A (en) | Traditional Chinese medicine composition for preventing and treating anemia and preparation method and application thereof | |
CN118490802B (en) | A composition for improving exercise-induced myocardial injury | |
CN100551357C (en) | Application of Yunzhi mycelium in preparation of anti-fatigue medicine | |
RU2752956C1 (en) | Method for increasing nonspecific resistance of body of calves | |
CN111298099A (en) | Iron-supplementing composition and preparation method and application thereof | |
RU2723179C1 (en) | Method for improving economic and useful qualities of ewes and lambs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhou Chuanshe Inventor after: Chen Liang Inventor after: Tan Zhiliang Inventor after: Kong Zhiwei Inventor after: Ba Sangzhuzha Inventor after: Li Bin Inventor after: Jiao Jinzhen Inventor after: Huang Ximei Inventor before: Zhou Chuanshe Inventor before: Chen Liang Inventor before: Tan Zhiliang Inventor before: Kong Zhiwei Inventor before: Ba Sangzhuzha Inventor before: Li Bin Inventor before: Jiao Jinzhen |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210915 Address after: 410125 no.644 Yuanda 2 Road, Furong district, Changsha City, Hunan Province Applicant after: INSTITUTE OF SUBTROPICAL AGRICULTURE, CHINESE ACADEMY OF SCIENCES Applicant after: Zhongshan Nenghe Biotechnology Co.,Ltd. Address before: 410125 no.644 Yuanda 2 Road, Furong district, Changsha City, Hunan Province Applicant before: INSTITUTE OF SUBTROPICAL AGRICULTURE, CHINESE ACADEMY OF SCIENCES |
|
GR01 | Patent grant | ||
GR01 | Patent grant |